|
Chronic myeloid leukemia (CML) is a malignant cancer of the blood that
affects people of all ages. While treatment is available for most of these
patients, approximately 20 percent of them do not respond to it. Researchers at
McGill teaching hospitals will soon study the effects of a new alternative
therapy.
"Gleevec(TM) has become the standard treatment for CML," says Dr. Carlo Gambacorti-Passerini, Canada Research Chair in Oncology at McGill University. "It is remarkably effective for most patients; however, some become resistant to it. We will be looking at a new drug called BMS-354825. The new research is planned to start in January at McGill University
teaching hospitals, the only institutes in Canada where this treatment will be
available. The hospitals that will test BMS-354825 include the Sir Mortimer B.
Davis Jewish General Hospital, the McGill University Health Centre and St.
Mary's Hospital.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links
|
